FDA Inspection 1238162 — U.S. Food And Drug Administration (FDA) Institutional Review Board (IRB)

U.S. Food And Drug Administration (FDA) Institutional Review Board (IRB) — FEI 1120137

The FDA completed an inspection of U.S. Food And Drug Administration (FDA) Institutional Review Board (IRB) on May 8, 2024 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 8, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Silver Spring, MD (United States)

Additional Details

IRB